Top Markets
#1 Black Phoenix Black Phoenix +736.57%
#2 Islamic Coin Islamic Coin +146.17%
#3 THORChain THORChain +26.71%
#4 MiL.k Alliance MiL.k Alliance +26.65%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.17%
#6 THORChain Yield THORChain Yield +20.24%
#7 Bless Bless +19.93%
#8 Wrapped STX (Velar) Wrapped STX (Velar) +14.36%
#9 TENDIES TENDIES +14.32%
#10 Tutorial Tutorial +12.78%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Aerovate Therapeutics, Inc. Aerovate Therapeutics, Inc.

Aerovate Therapeutics, Inc.

AVTE
Rank in Stocks #5459
Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise... Aerovate Therapeutics, Inc. is a clinical-stage biopharmaceutical enterprise focused on innovating therapies to enhance the well-being of patients afflicted with rare cardiopulmonary illnesses across the United States. The company's principal effort involves advancing AV-101, an inhaled dry powder variant of imatinib, which is currently undergoing a Phase 2b/Phase 3 clinical study for the management of pulmonary arterial hypertension. Established in 2018, Aerovate Therapeutics, Inc. maintains its corporate headquarters in Waltham, Massachusetts.
Share Price
$93.80
Last synced: 2025-04-28
Market Cap
$2.68B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Aerovate Therapeutics, Inc. (AVTE)

Category

Healthcare
Number of shares outstanding for Aerovate Therapeutics, Inc. (AVTE)
Number of shares outstanding as of June 2026: 61.05M
According to Aerovate Therapeutics, Inc. latest financial reports and stock price the company's current number of shares outstanding is 61.05M. At the end of December 2023 the company had 26.33M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Aerovate Therapeutics, Inc. (AVTE) from 2019 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
2026 (TTM) 61.05M 113.60%
2024 28.58M 8.55%
2023 26.33M 7.60%
2022 24.47M 0.25%
2021 24.41M 0.00%
2020 24.41M 0.00%
2019 24.41M 0.00%
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 315.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1.86%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 548.64%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 478.91M 684.45%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH